HomeCannabisCorbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global...

Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Published on

<br /> Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference<br />

PR Newswire



NORWOOD, Mass.


,


Sept. 12, 2022


/PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that

Yuval Cohen

, Ph.D., Chief Executive Officer of Corbus, will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference.   The hybrid conference will take place

September 12-14

, 2022.

A livestream of the virtual presentation is available on-demand beginning today,

Monday, September 12, 2022

at

7:00 AM ET

for those who are registered to attend the conference and will be accessible for 30 days on the H.C. Wainwright conference platform. For more information, please visit the

conference website

.


About Corbus

Corbus is an immunology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways.  Corbus’ current pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. Corbus is headquartered in

Norwood, Massachusetts

. For more information on Corbus, visit


corbuspharma.com


. Connect with us on


Twitter


,


LinkedIn


and


Facebook


.



INVESTOR CONTACT:





Sean Moran




[email protected]

Cision
View original content to download multimedia:

https://www.prnewswire.com/news-releases/corbus-pharmaceuticals-to-present-virtually-at-the-hc-wainwright-24th-annual-global-investment-conference-301621611.html

SOURCE Corbus Pharmaceuticals

rt Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Featured image: Megapixl © Maykal

Disclaimer

Latest News

Flora Growth Completes Multiple Commercial Cannabis Exports Into New International Markets

Flora (NASDAQ:FLGC) completed dry cannabis flower commercial exports to Switzerland and the Czech...

Global Hemp Fiber Market Rising at an Annual Rate of 6.9%

Las Vegas, NV, Sept. 22, 2022 (GLOBE NEWSWIRE) -- ...

Tilray Brands, Inc. to Announce First Quarter Fiscal 2023 Financial Results on October 7, 2022

NEW YORK and LEAMINGTON, Ontario, Sept. 23, 2022 (GLOBE...

Delta 9 Places 64th on The Globe and Mail’s Annual Ranking of Canada’s Top Growing Companies

WINNIPEG, Manitoba, Sept. 23, 2022 (GLOBE NEWSWIRE) -- DELTA...

More like this

Skye Bioscience Completes Drug Production for Phase 1 Clinical Study

San Diego, California, Sept. 20, 2022 (GLOBE NEWSWIRE) --...

VIVO Cannabis Announces Agreement to Amend Outstanding Debentures

Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX:...

High Tide Closes $19 Million Non-Dilutive Credit Facility with connectFirst Credit Union

High Tide Closes $19 Million Non-Dilutive Credit Facility...

Heritage Cannabis Acquires Remaining 25% of Voyage Cannabis Corp.

Toronto, ON, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Heritage...